Nixar (Bilastine)

Bilastine works as a selective peripheral H1‑receptor antagonist. By binding to H1 receptors on blood vessels and sensory nerves, it prevents histamine from triggering vasodilation, increased permeability, and nerve stimulation, thereby reducing the classic signs of an allergic response.

The dose of Nixar is determined by the prescribing healthcare professional. In most adult patients, a single oral tablet taken once daily is typical, but the exact regimen should follow the prescriber’s instructions and local labeling.

Safety data for bilastine during pregnancy are limited, so it should only be used if the potential benefit outweighs any risk. While breastfeeding, caution is advised because the drug may be excreted in breast milk; a healthcare provider should evaluate the need for treatment.

To order Nixar, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Bilastine offers a non‑sedating profile compared with first‑generation antihistamines and has comparable efficacy to other second‑generation agents such as cetirizine or loratadine. Its selective peripheral action reduces central nervous system penetration, making it a suitable option for patients who need minimal drowsiness.

Nixar tablets should be stored at ambient temperature, below 25 °C. Keep them in the original packaging, protect from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Nixar is taken orally, usually as a whole tablet with water. It can be taken with or without food, but should be swallowed whole and not chewed or crushed to ensure proper absorption.

Although rare, serious adverse reactions may include anaphylaxis, severe skin reactions such as Stevens‑Johnson syndrome, angioedema, cardiac arrhythmias, and significant liver injury. Patients should seek immediate medical attention if they experience symptoms like swelling of the face or throat, rash, or unexplained dizziness.

Nixar should be avoided in individuals with known hypersensitivity to bilastine or any tablet excipients. Caution is also advised for patients with severe renal impairment, pregnant or breastfeeding women unless directed by a physician, and those taking medications that strongly increase bilastine levels.